The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Editorial

Two sides of the coin

EuroIntervention 2020;15:1483-1484. DOI: 10.4244/EIJV15I17A271

1. Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN, USA


Randomised clinical trials help to study the science of what can be done and what can be accomplished. While these studies suffer from “entry” bias which dictates that there must be validated equipoise between the two approaches to be studied, they form the basis of the most highly controlled and highest levels of evidence in studying specific patient scenarios1,2. In contrast to randomised clinical trials, registries tell us what we are actually doing and have greater relevance to clinical practice at large. Both sides of the coin give very valuable, albeit different, data3,4.

The current single-centre ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Tackling prosthetic heart valve-related deterioration: Liège translational cardiovascular research programme